285 related articles for article (PubMed ID: 17194390)
21. Impact of genetic factors on dyslipidemia in HIV-infected patients starting antiretroviral therapy.
Egaña-Gorroño L; Martínez E; Cormand B; Escribà T; Gatell J; Arnedo M
AIDS; 2013 Feb; 27(4):529-38. PubMed ID: 23262498
[TBL] [Abstract][Full Text] [Related]
22. Management of Lipid Levels and Cardiovascular Disease in HIV-Infected Individuals: Just Give Them a Statin?
Stein JH
Top Antivir Med; 2016 Dec-2017 Jan; 23(5):169-73. PubMed ID: 27398770
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use.
Kwong GP; Ghani AC; Rode RA; Bartley LM; Cowling BJ; da Silva B; Donnelly CA; van Sighem AI; Cameron DW; Danner SA; de Wolf F; Anderson RM
AIDS; 2006 Oct; 20(15):1941-50. PubMed ID: 16988515
[TBL] [Abstract][Full Text] [Related]
24. [Lipid profile of atazanavir].
Martínez Chamorro E
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():34-40. PubMed ID: 20116615
[TBL] [Abstract][Full Text] [Related]
25. Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?
Bradbury RA; Samaras K
Diabetes Obes Metab; 2008 Jun; 10(6):441-50. PubMed ID: 17825081
[TBL] [Abstract][Full Text] [Related]
26. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
27. Diabetes and dyslipidaemia are associated with oxidative stress independently of inflammation in long-term antiretroviral-treated HIV-infected patients.
Bastard JP; Couffignal C; Fellahi S; Bard JM; Mentre F; Salmon D; Katlama C; Raffi F; Leport C; Capeau J;
Diabetes Metab; 2019 Dec; 45(6):573-581. PubMed ID: 30862472
[TBL] [Abstract][Full Text] [Related]
28. Short-Term Efficacy and Safety of Adding Ezetimibe to Current Regimen of Lipid-Lowering Drugs in Human Immunodeficiency Virus-Infected Thai Patients Treated with Protease Inhibitors.
Boonthos K; Puttilerpong C; Pengsuparp T; Manosuthi W
Jpn J Infect Dis; 2018 May; 71(3):220-224. PubMed ID: 29709973
[TBL] [Abstract][Full Text] [Related]
29. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection.
Silverberg MJ; Leyden W; Hurley L; Go AS; Quesenberry CP; Klein D; Horberg MA
Ann Intern Med; 2009 Mar; 150(5):301-13. PubMed ID: 19258558
[TBL] [Abstract][Full Text] [Related]
30. Lipid profile changes by high activity anti-retroviral therapy.
Duro M; Sarmento-Castro R; Almeida C; Medeiros R; Rebelo I
Clin Biochem; 2013 Jun; 46(9):740-4. PubMed ID: 23295258
[TBL] [Abstract][Full Text] [Related]
31. Lipid profile of HIV-infected patients in relation to antiretroviral therapy: a review.
Souza SJ; Luzia LA; Santos SS; Rondó PH
Rev Assoc Med Bras (1992); 2013; 59(2):186-98. PubMed ID: 23582562
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
[TBL] [Abstract][Full Text] [Related]
33. Influence of antiretroviral therapy on oxidative stress and cardiovascular risk: a prospective cross-sectional study in HIV-infected patients.
Masiá M; Padilla S; Bernal E; Almenar MV; Molina J; Hernández I; Graells ML; Gutiérrez F
Clin Ther; 2007 Jul; 29(7):1448-55. PubMed ID: 17825696
[TBL] [Abstract][Full Text] [Related]
34. Cardiac diastolic dysfunction is prevalent in HIV-infected patients.
Nayak G; Ferguson M; Tribble DR; Porter CK; Rapena R; Marchicelli M; Decker CF
AIDS Patient Care STDS; 2009 Apr; 23(4):231-8. PubMed ID: 19281430
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy.
Bergersen BM
Drugs; 2006; 66(15):1971-87. PubMed ID: 17100407
[TBL] [Abstract][Full Text] [Related]
36. Dyslipidemia in HIV patients.
Tungsiripat M; Aberg JA
Cleve Clin J Med; 2005 Dec; 72(12):1113-20. PubMed ID: 16392725
[TBL] [Abstract][Full Text] [Related]
37. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
[TBL] [Abstract][Full Text] [Related]
38. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes.
Scicali R; Di Pino A; Ferrara V; Urbano F; Piro S; Rabuazzo AM; Purrello F
Acta Diabetol; 2018 Mar; 55(3):209-218. PubMed ID: 29260404
[TBL] [Abstract][Full Text] [Related]
39. Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.
Sension M; Deckx H
AIDS Rev; 2015; 17(1):21-36. PubMed ID: 25472015
[TBL] [Abstract][Full Text] [Related]
40. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
